Making PhRMA the great convener: Chin's new quest
This article was originally published in Scrip
Executive Summary
Donna Young went to meet PhRMA’s new head of science and regulatory affairs, and Washington’s latest influencer, Dr William Chin to discuss the need for partnership and collaboration in drug development to meet the progression of disease.